Visioneering Technologies, Inc. & Lambda-X Develop Software to Show Accurate Power Profile of NaturalVue Multifocal Contact L...
22 Abril 2019 - 7:00AM
Business Wire
Key data output describes the NaturalVue
Multifocal power curve and its patented design
US-based medical device company and inventor of the NaturalVue®
(etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering
Technologies, Inc (ASX: VTI) (‘VTI’ or ‘The Company’) has
released additional data regarding its patented NaturalVue®
Multifocal (etafilcon A) 1 Day Contact Lens.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190422005125/en/
Figure 1 - NaturalVue Multifocal
Instantaneous vs. Sagittal Power Profile (Graphic: Business
Wire)
Scientific Interest
Practitioners employing VTI’s NaturalVue Multifocal in managing
myopia in children recently announced updated data demonstrating in
141 children that wearing NaturalVue MF decreased the progression
of myopia by an average of 90%, compared to the average progression
rate before wearing NaturalVue Multifocal1. The treatment effect,
which included up to four years of treatment with NaturalVue
Multifocal, was consistent over time and across clinical sites. The
strength of this clinical performance has created excitement in the
scientific community and generated greater interest in the design
and unique optical power profile of the NaturalVue Multifocal.
The patent for the design of the NaturalVue Multifocal describes
the optics of this unique, extended depth of focus lens in terms of
instantaneous power. While familiar to many specialists,
instantaneous power may be less familiar to the broader community.
VTI is releasing additional information to assist in the
understanding of the lens design.
The scientific community uses two methods of expressing the
power profile in a lens design:
- Sagittal (also called axial or
radial)
- Instantaneous (also called
tangential)
Both methods of description are useful in creating and
describing lens designs, but provide different information and are
used for different purposes.
Jim Schwiegerling, PhD., Professor of Optical Sciences &
Ophthalmology at the University of Arizona, commented on the
importance of the use of instantaneous profiling. He stated,
“Instantaneous power is good for progressive aspheric type lenses
because it illustrates the power progression more accurately, and
provides different information about the power profile than does
the sagittal description. However, instantaneous profiling is not
appropriate for describing lenses with annular rings of alternating
power because instantaneous overemphasizes the abrupt curvature
change at the boundaries of the rings. Sagittal power tends to
underestimate the curvature of the progressive aspheric lens but
does a good job with ring-type designs since it effectively ignores
the transition between the zones.”
The NaturalVue Multifocal contact lens is a progressive aspheric
lens, and is best described in terms of instantaneous power,
consistent with how VTI’s and many other engineers think about
progressive aspheric optical designs. However, wavefront metrology
typically describes power profiles in terms of sagittal power and
the conversions for calculating the instantaneous power were
lacking. VTI worked with Lambda-X, a world leader in ophthalmic
products including its NIMO instruments, to develop customized
software capable of measuring and illustrating the instantaneous
and sagittal power curves of the NaturalVue Multifocal, or any
other multifocal lens.
The Plot of Instantaneous vs. Sagittal Power Profile of the
NaturalVue Multifocal
The accompanying graph is a direct output from a NIMO wavefront
sensor of a -3.00D NaturalVue Multifocal lens over the central 5mm
optic zone. The Instantaneous profile is shown in red (“Instant”)
and the Sagittal profile is show in blue (“Radial”).
The Neurofocus Optics® technology of the NaturalVue Multifocal
relies on the rapid, continuous, and uninterrupted progression in
plus power to induce an aperture effect for clear vision at all
distances. The Instantaneous power representation of the lens
design correlates to the clinical performance. Published data
suggests that significant levels of plus power in the lens optical
design is important to addressing peripheral defocus in the eye,
which is a contributing factor in myopic progression2. The
progression of plus power in the NaturalVue Multifocal design is
significant enough to induce peripheral blur which generates a
virtual aperture effect for an extended depth of focus.
Importantly, there are no spherical regions in the NaturalVue
Multifocal power profile, a distinct and unique feature of this
lens.
VTI’s CEO, Dr Stephen Snowdy said: “The clinical results
of our NaturalVue Multifocal continue to generate a lot of interest
in the scientific and professional communities. We greatly
appreciate the work of the experts at Lambda-X who provided us with
a tool to measure and express the unique optics of the NaturalVue
Multifocal. Dr. Richard Griffin designed the lens based on complex
calculations to achieve this design. To finally have a tangible
measurement of the power curve is very satisfying for us and, we
hope, enlightening for those interested in better understanding the
science behind the excellent performance of our product.”
The full description of this information may be accessed at
https://vtivision.com/practitioners/naturalvue-multifocal-lens/the-science-of-naturalvue-multifocal/.
For a more detailed explanation, contact Dr. Peg Achenbach, VP of
Professional Services and Clinical Science, at
pachenbach@vtivision.com.
About Visioneering Technologies
Visioneering Technologies Inc. (ASX:VTI) is an innovative eye
care company committed to redefining vision. Since its founding in
2008, Visioneering has brought together clinical, marketing,
engineering, manufacturing and regulatory leaders from top vision
care businesses to provide new solutions for presbyopia, myopia and
astigmatism.
Headquartered in the US, Visioneering designs, manufactures,
sells and distributes contact lenses. Its flagship product is the
NaturalVue® Multifocal contact lens, and VTI has expanded its
portfolio of technologies to address a range of eye care issues.
The company has grown operations across the United States,
Australia and Europe and is expanding into Asia with a focus on
markets with high rates of myopia.
MKT-VTI-PR73 r1
1 Cooper, J, O’Connor, B, Aller T. Clinical Research Update with
NaturalVue Multifocal presented at Global Specialty Lens Symposia.
January, 2019.
2 Peripheral Hyperopia explanation summarised from:
- Gifford, P., &
Gifford, K. L. (2016). The Future of Myopia Control
Contact Lenses. Optometry and Vision Science. 93(4): 336-343.
- Smith, E. L., Kee, C.,
Ramamirtham, R., Qiao-Grider, Y., & Hung, L.
(2005). Peripheral Vision Can Influence Eye Growth and Refractive
Development in Infant Monkeys. Investigative Ophthalmology &
Visual Science. 46(11): 3965.
- Cooper, J., Schulman, E., Jamal,
N. (2012). Current Status on the Development and Treatment of
Myopia. Optometry. 83(5):179-199.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190422005125/en/
Layna L. MendlingerVisioneering Technologies,
Inc.info@vtivision.com
Visioneering Technologies (ASX:VTI)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Visioneering Technologies (ASX:VTI)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024